Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation

Biologicals

Volumn 37, Issue 4, 2009, Pages 259-269

  Sheng Fowler, Li ^a   Lewis Jr , Andrew M ^a   Peden, Keith ^a  

^a Division of Viral Products   (United States)

Author keywords

DNA inactivation; DNA infectivity; Vaccine cell substrates

Indexed keywords

CELL DNA; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROPIOLACTONE; VIRUS DNA;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; DNA DETERMINATION; EMBRYO; GENE INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROVIRUS; RETROVIRUS INFECTION; RISK ASSESSMENT; VACCINE PRODUCTION; VIRUS INFECTIVITY;

AIDS VACCINES; CELLS, CULTURED; CLONING, MOLECULAR; DISINFECTANTS; DNA, SUPERHELICAL; DNA, VIRAL; ENDODEOXYRIBONUCLEASES; ENDORIBONUCLEASES; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; PROPIOLACTONE; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; VIRUS INACTIVATION;

RETROVIRAL PROVIRUS;

EID: 67650604378     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.04.002     Document Type: Article

References (83)

1. Petricciani J.C., and Horaud F.N. DNA, dragons and sanity. Biologicals 23 3 (1995) 233-238
2. Griffiths E. Major issues associated with the use of cell substrates for the production of vaccines. Dev Biol 106 (2001) 25-35
3. Petricciani J., and Loewer J. An overview of cell DNA issues. Dev Biol 106 (2001) 275-282
4. Hilleman M.R. Line cell saga - an argument in favor of production of biologics in cancer cells. Adv Exp Med Biol 118 (1979) 47-58
5. Hilleman M.R. Cells, vaccines, and the pursuit of precedent. Natl Cancer Inst Monogr 29 (1968) 463-469
6. Krause P.R., and Lewis Jr. A.M. Safety of viral DNA in biological products. Biologicals 26 4 (1998) 317-320
7. Lewis Jr. A.M., Krause P., and Peden K. A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture. Dev Biol 106 (2001) 513-535
8. Diderholm H., and Wesslen T. Infection of naturally insusceptible cells with DNA of polyoma and Sv40 viruses. Acta Pathol Microbiol Scand 59 (1963) 271-272
9. Di Mayorca G.A., Eddy B.E., Stewart S.E., Hunter W.S., Friend C., and Bendich A. Isolation of infectious deoxribonucleic acid from SE polyoma-infected tissue cultures. Proc Natl Acad Sci U S A 45 (1959) 1805-1808
10. Orth G., Atanasiu P., Boiron M., Rebiere J.P., and Paoletti C. Infectious and oncogenic effect of DNA extracted from cells infected with polyoma virus. Proc Soc Exp Biol Med 115 (1964) 1090-1095
11. Gerber P. An infectious deoxyribonucleic acid derived from vacuolating virus (SV40). Virology 16 (1962) 96-97
12. McCutchan J.H., and Pagano J.S. Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst 41 2 (1968) 351-357
13. Graham F.L., and van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52 2 (1973) 456-467
14. van der Eb A.J., and Graham F.L. Assay of transforming activity of tumor virus DNA. Methods Enzymol 65 1 (1980) 826-839
15. van der Eb A.J., Mulder C., Graham F.L., and Houweling A. Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA. Gene 2 3-4 (1977) 115-132
16. Itani T., Ariga H., Yamaguchi N., Tadakuma T., and Yasuda T. A simple and efficient liposome method for transfection of DNA into mammalian cells grown in suspension. Gene 56 2-3 (1987) 267-276
17. Goldstein S., Fordis C.M., and Howard B.H. Enhanced transfection efficiency and improved cell survival after electroporation of G2/M-synchronized cells and treatment with sodium butyrate. Nucleic Acids Res 17 10 (1989) 3959-3971
18. Burnett J.P., and Harrington J.A. Infectivity associated with Simian adenovirus type SA7 DNA. Nature 220 173 (1968) 1245
19. Burnett J.P., and Harrington J.A. Simian adenovirus SA7 DNA: chemical, physical, and biological studies. Proc Natl Acad Sci U S A 60 3 (1968) 1023-1029
20. Sutjipto S., and Simmons D.G. Turkey respiratory tract adenoviruses: in vitro infectivity of purified DNA. Am J Vet Res 42 3 (1981) 495-497
21. Graham F.L. Covalently closed circles of human adenovirus DNA are infectious. EMBO J 3 12 (1984) 2917-2922
22. Watts S.L., Ostrow R.S., Phelps W.C., Prince J.T., and Faras A.J. Free cottontail rabbit papillomavirus DNA persists in warts and carcinomas of infected rabbits and in cells in culture transformed with virus or viral DNA. Virology 125 1 (1983) 127-138
23. Brandsma J.L., Yang Z.H., Barthold S.W., and Johnson E.A. Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A 88 11 (1991) 4816-4820
24. Brandsma J.L., and Xiao W. Infectious virus replication in papillomas induced by molecularly cloned cottontail rabbit papillomavirus DNA. J Virol 67 1 (1993) 567-571
25. McBride A.A., Dlugosz A., and Baker C.C. Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique. Proc Natl Acad Sci U S A 97 10 (2000) 5534-5539
26. Nasseri M., Meyers C., and Wettstein F.O. Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation. Virology 170 1 (1989) 321-325
27. Casal J.I., Diaz-Aroca E., Ranz A.I., and Manclus J.J. Construction of an infectious genomic clone of porcine parvovirus: effect of the 5′-end on DNA replication. Virology 177 2 (1990) 764-767
28. Laughlin C.A., Tratschin J.D., Coon H., and Carter B.J. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23 1 (1983) 65-73
29. Merchlinsky M.J., Tattersall P.J., Leary J.J., Cotmore S.F., Gardiner E.M., and Ward D.C. Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice. J Virol 47 1 (1983) 227-232
30. Senapathy P., and Carter B.J. Molecular cloning of adeno-associated virus variant genomes and generation of infectious virus by recombination in mammalian cells. J Biol Chem 259 7 (1984) 4661-4666
31. Zhi N., Zadori Z., Brown K.E., and Tijssen P. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318 1 (2004) 142-152
32. Samulski R.J., Berns K.I., Tan M., and Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A 79 6 (1982) 2077-2081
33. Fleckenstein B., Bornkamm G.W., and Ludwig H. Repetitive sequences in complete and defective genomes of Herpesvirus saimiri. J Virol 15 2 (1975) 398-406
34. Allen G.P., and Randall C.C. Biological properties of equine herpesvirus type 1 DNA: transfectivity and transforming capacity. Infect Immun 22 1 (1978) 34-40
35. Miller G., Grogan E., Heston L., Robinson J., and Smith D. Epstein-Barr viral DNA: infectivity for human placental cells. Science 212 4493 (1981) 452-455
36. Cameron I.R., Wilkie N.M., and Macnab J.C. The infectivity of herpes simplex virus DNA in rat embryo cells is enhanced synergistically by DMSO and glucose. J Virol Methods 6 4 (1983) 183-191
37. Tognon M., Cattozzo E.M., Bianchi S., and Romanelli M.G. Enhancement of HSV-DNA infectivity, in Vero and RS cells, by a modified calcium-phosphate transfection technique. Virus Genes 12 2 (1996) 193-197
38. Kaaden O.R. Transfection studies in vitro and in vivo with isolated Marek's disease virus DNA. IARC Sci Publ 24 2 (1978) 627-633
39. Scheiflinger F., Dorner F., and Falkner F.G. Construction of chimeric vaccinia viruses by molecular cloning and packaging. Proc Natl Acad Sci U S A 89 21 (1992) 9977-9981
40. Fisher A.G., Collalti E., Ratner L., Gallo R.C., and Wong-Staal F. A molecular clone of HTLV-III with biological activity. Nature 316 6025 (1985) 262-265
41. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59 2 (1986) 284-291
42. Barker C.S., Pickel J., Tainsky M., and Hunter E. Molecular cloning of the Mason-Pfizer monkey virus genome: biological characterization of genome length clones and molecular comparisons to other retroviruses. Virology 153 2 (1986) 201-214
43. Itohara S., and Sekikawa K. Molecular cloning of infectious proviral genomes of bovine leukemia virus. Virology 159 1 (1987) 158-160
44. Olmsted R.A., Barnes A.K., Yamamoto J.K., Hirsch V.M., Purcell R.H., and Johnson P.R. Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci U S A 86 7 (1989) 2448-2452
45. Regier D.A., and Desrosiers R.C. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 6 11 (1990) 1221-1231
46. Inabe K., Ikuta K., and Aida Y. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus. Virology 245 1 (1998) 53-64
47. Letvin N.L., Lord C.I., King N.W., Wyand M.S., Myrick K.V., and Haseltine W.A. Risks of handling HIV. Nature 349 6310 (1991) 573
48. Willems L., Portetelle D., Kerkhofs P., Chen G., Burny A., Mammerickx M., et al. In vivo transfection of bovine leukemia provirus into sheep. Virology 189 2 (1992) 775-777
49. Willems L., Kettmann R., Dequiedt F., Portetelle D., Voneche V., Cornil I., et al. In vivo infection of sheep by bovine leukemia virus mutants. J Virol 67 7 (1993) 4078-4085
50. Liska V., Khimani A.H., Hofmann-Lehmann R., Fink A.N., Vlasak J., and Ruprecht R.M. Viremia and AIDS in rhesus macaques after intramuscular inoculation of plasmid DNA encoding full-length SIVmac239. AIDS Res Hum Retroviruses 15 5 (1999) 445-450
51. Kent S.J., Dale C.J., Preiss S., and Purcell D.F. Evidence of recombination between 3′ and 5′ LTRs in macaques inoculated with SIV DNA. AIDS Res Hum Retroviruses 18 3 (2002) 227-230
52. Kent S.J., Dale C.J., Preiss S., Mills J., Campagna D., and Purcell D.F. Vaccination with attenuated simian immunodeficiency virus by DNA inoculation. J Virol 75 23 (2001) 11930-11934
53. Purcell D.F., Cameron P.U., Mills J., and Kent S. Infectivity of wild-type and deleted proviral SIV DNA. Dev Biol 106 (2001) 395-406
54. Perrin P., and Morgeaux S. Inactivation of DNA by beta-propiolactone. Biologicals 23 3 (1995) 207-211
55. Kubinski Z.O., and Kubinski H. Alterations in Bacillus subtilis transforming DNA induced by beta-propiolactone and 1,3-propane sultone, two mutagenic and carcinogenic alkylating agents. J Bacteriol 136 3 (1978) 854-866
56. Brown A., Consigli R.A., Zabielski J., and Weil R. Effect of beta-propiolactone inactivation of polyoma virus on viral functions. J Virol 14 4 (1974) 840-845
57. de Serres F.J., and Brockman H.E. Comparison of the spectra of genetic damage in formaldehyde-induced ad-3 mutations between DNA repair-proficient and -deficient heterokaryons of Neurospora crassa. Mutat Res 437 2 (1999) 151-163
58. Sauerbier W. Reaction of formaldehyde with deoxyribonucleic acid in phage T1. Nature 188 (1960) 327-329
59. Freifelder D., and Davison P.F. Physicochemical studies on the reaction between formaldehyde and DNA. Biophys J 3 (1963) 49-63
60. Peden K., Emerman M., and Montagnier L. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185 2 (1991) 661-672
61. Theodore T.S., Englund G., Buckler-White A., Buckler C.E., Martin M.A., and Peden K.W.C. Construction and characterization of a stable full-length macrophage- tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res Hum Retroviruses 12 3 (1996) 191-194
62. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36 1 (1977) 59-74
63. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90 18 (1993) 8392-8396
64. Weiss A., Wiskocil R.L., and Stobo J.D. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol 133 1 (1984) 123-128
65. Alkhatib G., Combadière C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272 5270 (1996) 1955-1958
66. Peden K.W.C., and Martin M.A. Virological and molecular genetic techniques for studies of established HIV isolates. In: Karn J. (Ed). HIV: a practical approach: virology and immunology vol. 1 (1995), IRL Press, Oxford 21-45
67. Goff S., Traktman P., and Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol 38 1 (1981) 239-248
68. Brusick D.J. The genetic properties of beta-propiolactone. Mutat Res 39 3-4 (1977) 241-255
69. Morgeaux S., Tordo N., Gontier C., and Perrin P. Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus. Vaccine 11 1 (1993) 82-90
70. Acceptability of cell substrates for production of biologicals (1987), World Health Organization, Geneva
71. WHO Expert Committee on Biological Standardization (1998), World Health Organization, Geneva
72. Lebron J.A., Troilol P.J., Pacchione S., Griffiths T.G., Harper L.B., Mixson L.A., et al. Adaptation of the WHO guideline for residual DNA in parenteral vaccines produced on continuous cell lines to a limit for oral vaccines. Dev Biol (Basel) 123 (2006) 35-44
73. Guidelines to assure the quality, safety and efficacy of live attenuated rotavirus vaccines (Oral). Annex 3 (2005), World Health Organization
74. Sheng L., Cai F., Zhu Y., Pal A., Athanasiou M., Orrison B., et al. Oncogenicity of DNA in vivo: tumor induction with expression plasmids for activated H-ras and c-myc. Biologicals 36 (2008) 184-197
75. Jung A., Maier R., Vartanian J.P., Bocharov G., Jung V., Fischer U., et al. Multiply infected spleen cells in HIV patients. Nature 418 6894 (2002) 144
76. Lancaster W.D., Olson C., and Meinke W. Quantitation of bovine papilloma viral DNA in viral-induced tumors. J Virol 17 3 (1976) 824-831
77. Moar M.H., Campo M.S., Laird H.M., and Jarrett W.F. Unintegrated viral DNA sequences in a hamster tumor induced by bovine papillomavirus. J Virol 39 3 (1981) 945-949
78. Stevens J.G., and Wettstein F.O. Multiple copies of Shope virus DNA are present in cells of benign and malignant non-virus-producing neoplasms. J Virol 30 3 (1979) 891-898
79. Dürst M., Kleinheinz A., Hotz M., and Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 66 Pt 7 (1985) 1515-1522
80. Wickenden C., Malcolm A.D., Byrne M., Smith C., Anderson M.C., and Coleman D.V. Prevalence of HPV DNA and viral copy numbers in cervical scrapes from women with normal and abnormal cervices. J Pathol 153 2 (1987) 127-135
81. Bedell M.A., Hudson J.B., Golub T.R., Turyk M.E., Hosken M., Wilbanks G.D., et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol 65 5 (1991) 2254-2260
82. Major T., Szarka K., Sziklai I., Gergely L., and Czegledy J. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 58 1 (2005) 51-55
83. Israel M.A., Chan H.W., Hourihan S.L., Rowe W.P., and Martin M.A. Biological activity of polyoma viral DNA in mice and hamsters. J Virol 29 3 (1979) 990-996